GUFIC BIOSCIENCES
|
GUFIC BIOSCIENCES Last 5 Year Cashflow Statement History
[Consolidated]
| Mar2025 | Mar2024 | |
|---|---|---|
| Profit Before Tax | ₹94 Cr | ₹116 Cr |
| Adjustment | ₹44 Cr | ₹34 Cr |
| Changes In working Capital | ₹7.44 Cr | ₹-130 Cr |
| Cash Flow after changes in Working Capital | ₹145 Cr | ₹20 Cr |
| Cash Flow from Operating Activities | ₹123 Cr | ₹-7.46 Cr |
| Cash Flow from Investing Activities | ₹-71 Cr | ₹-102 Cr |
| Cash Flow from Financing Activities | ₹-37 Cr | ₹82 Cr |
| Net Cash Inflow / Outflow | ₹15 Cr | ₹-27 Cr |
| Opening Cash & Cash Equivalents | ₹1.14 Cr | ₹29 Cr |
| Cash & Cash Equivalent on Amalgamation / Take over / Merger | - | - |
| Cash & Cash Equivalent of Subsidiaries under liquidations | - | - |
| Translation adjustment on reserves / op cash balalces frgn subsidiaries | - | - |
| Effect of Foreign Exchange Fluctuations | - | - |
| Closing Cash & Cash Equivalent | ₹16 Cr | ₹1.14 Cr |
Compare Cashflow Statement of peers of GUFIC BIOSCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GUFIC BIOSCIENCES | ₹3,905.7 Cr | 2.1% | 1% | -1.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹477,312.0 Cr | 0.8% | 6.3% | 18.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹213,879.0 Cr | 8.6% | 20.7% | 18.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹194,094.0 Cr | 1.7% | 9.4% | 38.5% | Stock Analytics | |
| CIPLA | ₹118,993.0 Cr | 4.5% | 1.2% | -1.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹95,787.4 Cr | -0.3% | -14.8% | -9.5% | Stock Analytics | |
GUFIC BIOSCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GUFIC BIOSCIENCES | 2.1% |
1% |
-1.9% |
| SENSEX | 2.7% |
1.5% |
-5.6% |
You may also like the below Video Courses